insights_auto
Why is IBRX down ၈.၃၇%?
Dive Deeperchevron_right
IBRX:NASDAQ
Immunitybio Inc
၆.၀၂ US$
arrow_downward
-၈.၃၇%(-၀.၅၅) 1D
၆.၀၈ US$
arrow_upward
+၁.၀၈% (+၀.၀၆၅)bedtimeAfter hours
Closed: နို ၂၀, GMT-၅ ၁၆:၀၀:၀၃ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IBRX...
Open
၆.၄၁ US$
High
၆.၅၃ US$
Low
၆.၀၀ US$
Mkt. cap
၆၄၀.၄၂ ဋေ
Avg. vol.
၁.၄၄ ကုဋေ
Volume
၁.၀၆ ကုဋေ
52-wk high
၁၂.၄၃ US$
52-wk low
၁.၉၅ US$
EPS
-၁.၀၇ US$
Beta
၀.၁၇
Shares outstanding
၁၀၆.၃၈ ဋေ
No. of employees
၆၈၈
Open
၆.၄၁ US$
High
၆.၅၃ US$
Low
၆.၀၀ US$
Mkt. cap
၆၄၀.၄၂ ဋေ
Avg. vol.
၁.၄၄ ကုဋေ
Volume
၁.၀၆ ကုဋေ
52-wk high
၁၂.၄၃ US$
52-wk low
၁.၉၅ US$
EPS
-၁.၀၇ US$
Beta
၀.၁၇
Shares outstanding
၁၀၆.၃၈ ဋေ
No. of employees
၆၈၈
News stories
From web sources and news partners
Yahoo Finance
·
ပြီးခဲ့သည့် ၄ နာရီ
Does ImmunityBio, Inc. (IBRX) Have More Upside on Major ANKTIVA Milestones
Seeking Alpha
·
ပြီးခဲ့သည့် ၁ ရက်
ImmunityBio: Q3 ANKTIVA Slowdown And Cash Burn Reaffirm My Sell Rating
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ ရက်
ImmunityBio Named No. 2 Fastest-Growing Technology Company in North America on the 2026 Deloitte Technology Fast 500™
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ ရက်
ImmunityBio (IBRX) Could Be 53% Undervalued As Anktiva Trial Results Lift FDA Hopes
About Immunitybio Inc